Literature DB >> 11605042

Over-expression of vascular endothelial growth factor after preoperative radiation therapy for rectal cancer.

M Nozue1, N Isaka, K Fukao.   

Abstract

Vascular endothelial growth factor expression before and after preoperative radiation therapy was examined in 16 stage III rectal carcinoma patients. The biopsied tissues before preoperative radiation therapy and the tissues at operation were immunohistochemically stained. Four cases were negative for VEGF expression before radiation, but the other 12 cases were positive, with 4 cases showing strong immunoreactivity. After radiation, all except 1 case showed VEGF positive patterns, in which 14 cases demonstrated strong staining. In 12 cases, VEGF expression became higher after radiation therapy than before, as compared to the only 1 case that showed lower expression than before.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11605042     DOI: 10.3892/or.8.6.1247

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  12 in total

1.  Expression of vascular endothelial growth factor can predict distant metastasis and disease-free survival for clinical stage III rectal cancer following 30-Gy/10-f preoperative radiotherapy.

Authors:  Yifan Peng; Lin Wang; Changzheng Du; Jin Gu
Journal:  Int J Colorectal Dis       Date:  2012-05-30       Impact factor: 2.571

Review 2.  Interval to surgery after neoadjuvant treatment for colorectal cancer.

Authors:  Nir Wasserberg
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

3.  Updating advances on recombinant human endostatin combined with radiotherapy for non-small cell lung cancer with brain metastasis.

Authors:  Xiao-Dong Jiang; Yun Qiao
Journal:  Transl Lung Cancer Res       Date:  2012-03

4.  Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis.

Authors:  Inês Sofia Vala; Leila R Martins; Natsuko Imaizumi; Raquel J Nunes; José Rino; François Kuonen; Lara M Carvalho; Curzio Rüegg; Isabel Monteiro Grillo; João Taborda Barata; Marc Mareel; Susana Constantino Rosa Santos
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

5.  Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma.

Authors:  Kenneth L van Golen; LiWei Bao; George J Brewer; Kenneth J Pienta; Jeffrey M Kamradt; Donna L Livant; Sofia D Merajver
Journal:  Neoplasia       Date:  2002 Sep-Oct       Impact factor: 5.715

6.  Phase I study of 5-fluorouracil, leucovorin and bevacizumab in combination with radiation therapy in patients with locally advanced rectal cancer.

Authors:  Yasuhiro Inoue; Masato Okigami; Aya Kawamoto; Yoshinaga Okugawa; Junichiro Hiro; Susumu Saigusa; Yuji Toiyama; Koji Tanaka; Yasuhiko Mohri; Masato Kusunoki
Journal:  Mol Clin Oncol       Date:  2013-02-20

7.  Low Mmp 9 and VEGF levels predict good oncologic outcome in mid and low rectal cancer patients with neoadjuvant chemoradiation.

Authors:  Atilla Kurt; Fatih Yanar; Oktar Asoglu; Emre Balik; Vakur Olgac; Hasan Karanlik; Sevda Tanrikulu Kucuk; Evin Ademoglu; Gulcin Yegen; Dursun Bugra
Journal:  BMC Clin Pathol       Date:  2012-12-31

8.  Radiation-induced VEGF-C expression and endothelial cell proliferation in lung cancer.

Authors:  Yu-Hsuan Chen; Shiow-Lin Pan; Jing-Chi Wang; Sung-Hsin Kuo; Jason Chia-Hsien Cheng; Che-Ming Teng
Journal:  Strahlenther Onkol       Date:  2014-07-03       Impact factor: 3.621

9.  Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy.

Authors:  I Zlobec; T Vuong; C C Compton; A Lugli; R P Michel; S Hayashi; J R Jass
Journal:  Br J Cancer       Date:  2008-01-08       Impact factor: 7.640

10.  The changes of tumour vascular endothelial growth factor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma.

Authors:  David Buka; Josef Dvorak; Veronika Sitorova; Igor Sirak; Rene Voboril; Bohuslav Melichar; Igor Richter
Journal:  Contemp Oncol (Pozn)       Date:  2017-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.